So far, so good for lung cancer SBRT.


In this issue of the Journal of Thoracic Oncology, Stephans et al. from the Cleveland Clinic report their review of pulmonary function testing (PFT) before and after stereotactic body radiation therapy (SBRT) for stage I lung cancer.1 Though retrospective, this contribution is meaningful. The “believers” know that SBRT offers a substantial improvement in… (More)
DOI: 10.1097/JTO.0b013e3181a99bda


  • Presentations referencing similar topics